Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants
暂无分享,去创建一个
Pascal Clayette | M. Turco | D. Salvemini | Carolina Muscoli | Daniela Salvemini | V. Mollace | C. Muscoli | P. Clayette | Vincenzo Mollace | Hans S.L.M. Nottet | Maria C. Turco | Carlo F. Perno | H. Nottet | C. Perno
[1] S. Moncada,et al. Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.
[2] S. Cuzzocrea,et al. A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. , 1999, Science.
[3] Manisha N. Patel,et al. Metalloporphyrin class of therapeutic catalytic antioxidants. , 1999, Trends in pharmacological sciences.
[4] M. Tardieu. HIV-1-related central nervous system diseases. , 1999, Current opinion in neurology.
[5] R. Testi,et al. Primary macrophages infected by human immunodeficiency virus trigger CD95‐mediated apoptosis of uninfected astrocytes , 2000, Journal of leukocyte biology.
[6] S. Snyder,et al. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[7] J. Stamler,et al. Redox signaling: Nitrosylation and related target interactions of nitric oxide , 1994, Cell.
[8] G. Nisticó,et al. Cytokine-induced nitric oxide generation by cultured astrocytoma cells involves Ca(++)-calmodulin-independent NO-synthase. , 1993, Biochemical and biophysical research communications.
[9] H. Gendelman,et al. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease , 1992, The Journal of experimental medicine.
[10] L. Epstein,et al. HIV‐1‐induced neuronal injury in the developing brain , 1999, Journal of leukocyte biology.
[11] J S Beckman,et al. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. , 1992, Archives of biochemistry and biophysics.
[12] K. Schwarz,et al. Oxidative stress during viral infection: a review. , 1996, Free radical biology & medicine.
[13] S. Pillet,et al. The role of phagocytes in HIV-related oxidative stress. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[14] A. Finazzi-Agro’,et al. Involvement of interleukin-1β in the mechanism of human immunodeficiency virus type 1 (HIV-1) recombinant protein gp120-induced apoptosis in the neocortex of rat , 1999, Neuroscience.
[15] S. J. Kim,et al. Suppression of intracellular hydrogen peroxide generation and catalase levels in CD8+ T-lymphocytes from HIV+ individuals. , 1998, Free radical biology & medicine.
[16] J. Coyle,et al. Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.
[17] P. Portegies,et al. Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection. , 1999, Journal of immunology.
[18] F. Bloom,et al. Inflammatory cytokines: putative regulators of neuronal and neuro-endocrine function 1 Published on the World Wide Web on 24 October 1997. 1 , 1998, Brain Research Reviews.
[19] M. Currie,et al. Protective effects of a superoxide dismutase mimetic and peroxynitrite decomposition catalysts in endotoxin‐induced intestinal damage , 1999, British journal of pharmacology.
[20] K. Clouse,et al. Human immunodeficiency virus-1-infected macrophages induce inducible nitric oxide synthase and nitric oxide (NO) production in astrocytes: astrocytic NO as a possible mediator of neural damage in acquired immunodeficiency syndrome. , 1999, Blood.
[21] G. Nisticó,et al. Release of nitric oxide from astroglial cells: a key mechanism in neuroimmune disorders. , 1995, Advances in neuroimmunology.
[22] H. Schnaper,et al. HIV-1 infection alters monocyte interactions with human microvascular endothelial cells. , 1995, Journal of immunology.
[23] Howard E. Gendelman,et al. Dementia Associated with the Acquired Immunodeficiency Syndrome , 1995 .
[24] M. Roederer,et al. Glutathione deficiency is associated with impaired survival in HIV disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[25] G. Curran,et al. Postischemic, systemic administration of polyamine-modified superoxide dismutase reduces hippocampal CA1 neurodegeneration in rat global cerebral ischemia , 1997, Brain Research.
[26] J S Beckman,et al. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.
[27] H. Gendelman,et al. Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection. , 1990, Annual review of immunology.
[28] M. Rice,et al. Differential compartmentalization of brain ascorbate and glutathione between neurons and glia , 1997, Neuroscience.
[29] S. Lipton,et al. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[30] A. Cross,et al. Astrocytes and central nervous system endothelial cells do not express B7-1 (CD80) or B7-2 (CD86) immunoreactivity during experimental autoimmune encephalomyelitis , 2000, Journal of Neuroimmunology.
[31] G. Nisticó,et al. The HIV envelope protein gp120 in the nervous system: interactions with nitric oxide, interleukin-1beta and nerve growth factor signalling, with pathological implications in vivo and in vitro. , 1998, Biochemical pharmacology.
[32] J. Sidtis,et al. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. , 1988, Science.
[33] R. Natarajan,et al. Molecular Mechanisms of Tumor Necrosis Factor α Gene Expression in Monocytic Cells via Hyperglycemia-induced Oxidant Stress-dependent and -independent Pathways* , 2000, The Journal of Biological Chemistry.
[34] Y. Hannun,et al. Platelet-activating Factor Receptor Activation , 1998, The Journal of Biological Chemistry.
[35] J. Verhoef,et al. Monocyte infiltration is highly associated with loss of the tight junction protein zonula occludens in HIV‐1‐associated dementia , 2000, Neuropathology and applied neurobiology.
[36] K. Ikuta,et al. Amplification of superoxide anion generation in phagocytic cells by HIV‐1 infection , 1993, FEBS letters.
[37] G. Nisticó,et al. The effect of nitric oxide on cytokine‐induced release of PGE2 by human cultured astroglial cells , 1998, British journal of pharmacology.
[38] S. Moncada,et al. Nitric oxide: from discovery to the clinic. , 1998, Trends in pharmacological sciences.
[39] Jerry R. Mitchell,et al. Plasma glutathione and glutathione disulfide in the rat: regulation and response to oxidative stress. , 1983, The Journal of pharmacology and experimental therapeutics.
[40] E. Roche,et al. The keys of oxidative stress in acquired immune deficiency syndrome apoptosis. , 1998, Medical hypotheses.
[41] J. Weiss,et al. Mechanisms of leukocyte trafficking into the CNS. , 2000, Journal of neurovirology.
[42] G. W. Pace,et al. The role of oxidative stress in HIV disease. , 1995, Free radical biology & medicine.
[43] A. Cross,et al. A catalyst of peroxynitrite decomposition inhibits murine experimental autoimmune encephalomyelitis , 2000, Journal of Neuroimmunology.
[44] N. Greig,et al. Chemokine receptor mRNA expression at the in vitro blood-brain barrier during HIV infection. , 1999, Neuroreport.
[45] K. Raivio,et al. Expression of antioxidant enzymes in human inflammatory cells. , 2000, American journal of physiology. Cell physiology.
[46] A. Bowie,et al. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. , 2000, Biochemical pharmacology.
[47] J. Rabkin,et al. Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function , 1998, AIDS.
[48] G. Nisticó,et al. HIV gp120 glycoprotein stimulates the inducible isoform of no synthase in human cultured astrocytoma cells. , 1993, Biochemical and biophysical research communications.
[49] B. K. Park,et al. The role of glutathione in the neurotoxicity of artemisinin derivatives in vitro. , 2001, Biochemical pharmacology.
[50] K. Hensley,et al. Increased oxidative stress brought on by pro-inflammatory cytokines in neurodegenerative processes and the protective role of nitrone-based free radical traps. , 1999, Life Science.
[51] H. Gendelman,et al. Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA , 1995, Molecular and cellular biology.
[52] F. Ensoli,et al. Role of immune-derived diffusible mediators in AIDS-associated neurological disorders. , 2000, Archivum immunologiae et therapiae experimentalis.
[53] H. Forman,et al. Molecular Mechanism of Decreased Glutathione Content in Human Immunodeficiency Virus Type 1 Tat-transgenic Mice* , 2000, The Journal of Biological Chemistry.
[54] A. Lazzarin,et al. Cerebrospinal fluid S-adenosylmethionine (SAMe) and glutathione concentrations in HIV infection Effect of parenteral treatment with SAMe , 1995, Neurology.
[55] F. Aillet,et al. Redox status of cells influences constitutive or induced NF-kappa B translocation and HIV long terminal repeat activity in human T and monocytic cell lines. , 1992, Journal of immunology.
[56] H. Xiong,et al. HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: relevance for HIV-1-associated dementia. , 2000, Journal of neurovirology.